Haleon/$HLN
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Haleon
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.
Ticker
$HLN
Sector
Primary listing
NYSE
Employees
24,561
Headquarters
Website
Haleon Metrics
BasicAdvanced
$41B
40.73
$0.23
0.24
$0.18
2.69%
Price and volume
Market cap
$41B
Beta
0.24
52-week high
$11.42
52-week low
$8.86
Average daily volume
8.5M
Dividend rate
$0.18
Financial strength
Current ratio
0.87
Quick ratio
0.605
Long term debt to equity
48
Total debt to equity
53.413
Dividend payout ratio (TTM)
39.22%
Interest coverage (TTM)
6.38%
Profitability
EBITDA (TTM)
3,583.623
Gross margin (TTM)
63.56%
Net profit margin (TTM)
13.81%
Operating margin (TTM)
21.84%
Effective tax rate (TTM)
22.88%
Revenue per employee (TTM)
$614,100
Management effectiveness
Return on assets (TTM)
4.61%
Return on equity (TTM)
9.38%
Valuation
Price to earnings (TTM)
40.733
Price to revenue (TTM)
5.59
Price to book
1.92
Price to tangible book (TTM)
-3.25
Price to free cash flow (TTM)
28.718
Free cash flow yield (TTM)
3.48%
Free cash flow per share (TTM)
0.323
Dividend yield (TTM)
1.91%
Forward dividend yield
2.69%
Growth
Revenue change (TTM)
-2.12%
Earnings per share change (TTM)
41.64%
3-year revenue growth (CAGR)
2.75%
3-year earnings per share growth (CAGR)
2.88%
What the Analysts think about Haleon
Analyst ratings (Buy, Hold, Sell) for Haleon stock.
Bulls say / Bears say
Haleon projects high single-digit adjusted operating profit growth starting in 2026, supported by stable demand in core markets and planned supply chain cost reductions, targeting productivity savings of £800 million over five years and cutting working capital by 30% annually to boost cash flow (Reuters)
In April 2025, Haleon acquired the remaining 12% of its Tianjin TSKF Chinese joint venture for ¥1.62 billion, making it a wholly owned subsidiary and gaining added strategic flexibility in a business that represents about 40% of its China revenues (Reuters)
Despite top-line pressures, Haleon’s adjusted operating profit for H1 2025 was £1.24 billion, above analyst expectations of £1.22 billion, showing strong margin gains from pricing actions and cost efficiencies (Reuters)
Haleon lowered its full-year organic revenue growth outlook to about 3.5% from the previous 4%–6%, after reporting H1 2025 organic growth of 3%, short of analysts’ 3.3% expectation (Reuters)
Weak consumer confidence and retailer inventory reductions in North America—Haleon’s biggest market—weighed on H1 2025 organic revenue growth at 3.2%, below the 3.4% analysts expected, highlighting ongoing U.S. challenges (Reuters)
After the revised outlook, Haleon’s shares fell by as much as 5% on July 31, 2025, reflecting investor doubts about the company’s ability to overcome its short-term growth hurdles (Reuters)
Data summarised monthly by Lightyear AI. Last updated on 30 Aug 2025.
Haleon Financial Performance
Revenues and expenses
Haleon Earnings Performance
Company profitability
Haleon News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
Sept18
Haleon
DividendPayment
$0.059783Per share
FAQs
What’s the current market cap for Haleon stock?
Haleon (HLN) has a market cap of $41B as of September 17, 2025.
What is the P/E ratio for Haleon stock?
The price to earnings (P/E) ratio for Haleon (HLN) stock is 40.73 as of September 17, 2025.
Does Haleon stock pay dividends?
Yes, the Haleon (HLN) stock pays dividends to shareholders. As of September 17, 2025, the dividend rate is $0.17731 and the yield is 2.69%. Haleon has a payout ratio of 39.22% on a trailing twelve-month basis.
When is the next Haleon dividend payment date?
The next Haleon (HLN) dividend payment is scheduled for September 18, 2025.
What is the beta indicator for Haleon?
Haleon (HLN) has a beta rating of 0.24. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.